The stock market continues to keep sellers at bay, offering few reasons to fight the tape

  • 📰 CNBC
  • ⏱ Reading Time:
  • 46 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 22%
  • Publisher: 72%

Nigeria News News

Nigeria Nigeria Latest News,Nigeria Nigeria Headlines

New for subscribers: The stock market continues to keep sellers at bay, offering few reasons to fight the tape. Check out CNBCPro today.

leading to a sprightly rally to new record highs is a fitting turn for a stock market whose defining feature right now is a dearth of determined sellers.

That was Friday's story, a 700,000-job shortfall in April relative to forecasts acting as an excuse for a relief bid in underperforming growth stocks with no evidence from sturdy cyclical sectors that investors were rethinking the near-universal expectations for a strong U.S. economic revival underway.

Of course, every share that's bought is also sold. And, for sure, many precincts of the market — speculative-growth stocks, IPOs, alternative-energy plays — have indeed been battered by liquidations. But the selling has been localized, and money has generally migrated into other groups rather than out of the market, leading to the unflappably rotating advanceTrading volumes in stocks and options have ebbed over the past several weeks — not unusual in a grinding uptrend but supportive of the idea that would-be sellers are content to let their equity allocations drift higher.

 

Thank you for your comment. Your comment will be published after being reviewed.
Please try again later.

Pro thanks for this news

We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

 /  🏆 12. in NG

Nigeria Nigeria Latest News, Nigeria Nigeria Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

Novavax, Tesla, Match, Palantir: What to Watch When the Stock Market Opens TodayTech stocks keep slipping and Novavax is tumbling after it delayed seeking clearance for its vaccine.
Source: WSJ - 🏆 98. / 63 Read more »